A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors

Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors

NCT04980690 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Clinical Study of 9MW2821 Monotherapy or Combined With Other Anticancer Therapy in Advanced Solid Tumors

NCT06947226 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Phase I Clinical Trial of BH002 in Patients With Advanced Solid Tumors

NCT06231277 ·Status: COMPLETED ·Phase: PHASE1

A Study of IBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

NCT06198426 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients

NCT06212076 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Clinical Study to Evaluate the Efficacy and Safety of SI-B001 in the Treatment of Recurrent and Metastatic HNSCC

NCT05044897 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors

NCT07136142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

NCT06349408 ·Status: RECRUITING ·Phase: PHASE1

IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

NCT06974812 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors

NCT05773937 ·Status: RECRUITING ·Phase: PHASE1

A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors.

NCT06266923 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors

NCT05990452 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

NCT04934514 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Phase I/Ib Multiple Ascending Dose Study in China

NCT03523390 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors

NCT07229612 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors

NCT04708210 ·Status: UNKNOWN ·Phase: PHASE1

A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors

NCT07231211 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma (G-HOPE-001)

NCT06238843 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer

NCT05949606 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

NCT06963281 ·Status: RECRUITING ·Phase: PHASE1

A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors

NCT05636215 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China

NCT01863485 ·Status: COMPLETED ·Phase: PHASE1

The Primary Objective of This Study to Evaluate the Safety and Tolerability of IBI334 and Determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D)and Anti Tumor Activity of IBI334.

NCT05774873 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor

NCT05997342 ·Status: COMPLETED ·Phase: PHASE1

Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

NCT06414460 ·Status: RECRUITING ·Phase: PHASE1